SIREN : 891090680
EUROAPI FRANCE is a French company founded 5 years ago, specialized in the sector Fabrication de produits pharmaceutiques de base. Based in PARIS (75011), this company of category ETI shows in 2024 a revenue of 439.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 439 611 237 € | 434 740 347 € | 397 084 303 € | 74 299 424 € |
| Net income | -35 277 579 € | -77 001 520 € | -3 789 018 € | -9 326 204 € |
| EBITDA | 1 048 699 € | 11 529 074 € | 15 109 879 € | -15 378 776 € |
| Net margin | -8.0% | -17.7% | -1.0% | -12.6% |
In 2024, EUROAPI FRANCE achieves revenue of 439.6 M€. Over the period 2021-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +80.9%. Vs 2023: +1%. After deducting consumption (131.4 M€), gross margin stands at 308.2 M€, i.e. a rate of 70%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.0 M€, representing 0.2% of revenue. Warning negative scissor effect: despite revenue change (+1%), EBITDA varies by -91%, reducing margin by 2.4 pts. This reflects costs rising faster than revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -35.3 M€ (-8.0% of revenue), which will impact equity.
439 611 237 €
308 207 924 €
1 048 699 €
-18 821 699 €
-35 277 579 €
0.2%
The debt ratio (= Financial debt / Equity x 100) stands at 64%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
64.464%
45.119%
-1.343%
-35.825
30.9%
In 2024, the debt ratio of EUROAPI FRANCE (64.46) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of EUROAPI FRANCE (45.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of EUROAPI FRANCE (-35.83) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 280.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 999.2x. Operating income very largely covers interest expenses: high safety margin.
280.112
999.168
In 2024, the liquidity ratio of EUROAPI FRANCE (280.11) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of EUROAPI FRANCE (999.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 97 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 106 days. Favorable situation: supplier credit is longer than customer credit by 9 days. Inventory turnover is 196 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 275 days of revenue, i.e. 336.3 M€ to permanently finance.
336 285 012 €
97 j
106 j
196 j
275 j
Compare EUROAPI FRANCE with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de produits pharmaceutiques de base
The revenue of EUROAPI FRANCE in 2024 is 439.6 M€.
EUROAPI FRANCE recorded a net loss in 2024.
The headquarters of EUROAPI FRANCE is located in PARIS (75011), in the department Paris.
The tax return of EUROAPI FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
EUROAPI FRANCE operates in the sector Fabrication de produits pharmaceutiques de base (NAF code 21.10Z). See the 'Sector positioning' section above to compare the company with its competitors.